₹ 9,945.50
165.50 (1.69%)
D
Divis Laboratories
₹ 9,945.50
Divis Laboratories EPS Summary (consolidated)
The latest quarterly EPS of Divis Laboratories as of Q1 Jun 2026 stands at ₹33.95. This is a 19.92% growth quarter on quarter and 65.69% growth same quarter last year. The forecasted EPS for Q1 Jun 2026 was ₹24.01. It beat the estimate by ₹9.95. For the FY2026 the EPS of Divis Laboratories stands at ₹96.75. This is a 17.23% growth compared with FY2025.
Divis Laboratories EPS
EPS by Peers

S
Sun Pharmaceutical

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science

C
Cipla
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

